Company Overview of PrIME Biologics Pte Ltd.
PrIME Biologics Pte Ltd. develops and manufactures therapeutic plasma products. It develops therapeutic Albumin, IVIG, FVIII, and FIX from human plasma; other therapeutic plasma based products; and hyperimmune therapies and specialty plasma therapeutics. PrIME Biologics Pte Ltd. was formerly known as Singapharm Pte Ltd. and changed its name to PrIME Biologics Pte Ltd. in August 2011. The company was incorporated in 2010 and is based in Singapore. PrIME Biologics Pte Ltd. is a former subsidiary of NuSep Holdings Ltd.
41 Science Park Road
#01-09 The Gemini (Lobby A)
Founded in 2010
65 6410 2410
Key Executives for PrIME Biologics Pte Ltd.
PrIME Biologics Pte Ltd. Key Developments
Similar Private Companies By Industry
|ASLAN Pharmaceuticals Pte. Ltd.||Asia|
|Attogenix Biosystems Pte Ltd||Asia|
|Biotech Research Ventures Pte. Ltd.||Asia|
|China Agro-Technology Holdings Ltd.||Asia|
|Clearbridge NanoMedics Pte Ltd.||Asia|
Recent Private Companies Transactions
May 16, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact PrIME Biologics Pte Ltd., please visit primebiologics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.